日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ischemic Lesions in Diffusion-Weighted Imaging after Carotid Artery Stenting: Correlation with Access Route

颈动脉支架置入术后弥散加权成像显示的缺血性病变:与入路方式的相关性

Shimonaga, Koji; Hirata, Yoshito; Mitsunobu, Masakazu; Ogami, Ryo; Kiura, Yoshihiro; Tominaga, Atsushi; Horie, Nobutaka

EXTH-42. Lost in translation: Do preclinical studies predict clinical failure in GBM?

EXTH-42. 翻译中的误区:临床前研究能否预测 GBM 的临床失败?

Ochi, Nobuaki; Yamane, Hiromichi; Hotta, Katsuyuki; Fujii, Hiromi; Isozaki, Hideko; Honda, Yoshihiro; Yamagishi, Tomoko; Kubo, Toshio; Tanimoto, Mitsune; Kiura, Katsuyuki; Takigawa, Nagio; Andrade, R P L; Gil, N P; Costa, A L; Brás, J; Castro, N; Sousa, R; Vaz, R P; Martins, J; Almeida, E; Abreu, J; Afonso, H; Jungwirth, Gerhard; Paul, Adrian; Junguo, Cao; Unterberg, Andreas; Abdollahi, Amir; Herold-Mende, Christel; Selvi, P; Pérez, O Montero; Madroñal, IM Carrión; Yañez, D; Martin, CBocanegra; Karbhari, Nishika; Kizilbash, Sani; Campian, Jian; Elmquist, William; Galanis, Evanthia; Sarkaria, Jann

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

血浆S100A8/A9水平可预测晚期非小细胞肺癌患者对免疫检查点抑制剂的反应

Kuribayashi, Tadahiro; Kinoshita, Rie; Ninomiya, Kiichiro; Makimoto, Go; Kubo, Toshio; Rai, Kammei; Ichihara, Eiki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki; Toyooka, Shinichi; Sakaguchi, Masakiyo; Ohashi, Kadoaki

Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors

二甲双胍联合纳武利尤单抗治疗难治性/复发性实体瘤的Ib期剂量探索和药代动力学试验

Kubo, Toshio; Kato, Hironari; Horiguchi, Shigeru; Kozuki, Toshiyuki; Asagi, Akinori; Yoshida, Michihiro; Udono, Heiichiro; Kiura, Katsuyuki; Hotta, Katsuyuki

Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up

晚期胰腺癌患者接受纳武利尤单抗联合二甲双胍治疗后获得持久疗效:一例随访七年的病例报告

Sato, Ryosuke; Hotta, Katsuyuki; Kubo, Toshio; Horiguchi, Shigeru; Kato, Hironari; Matsumoto, Kazuyuki; Kozuki, Toshiyuki; Udono, Heiichiro; Kiura, Katsuyuki; Otsuka, Motoyuki

Retreatment With EGFR-Tyrosine Kinase Inhibitor After Disease Progression Following Gefitinib Induction and Chemoradiotherapy in EGFR-Mutant Stage III Non-small Lung Cancer: An Efficacy and Safety Analysis of the LOGIK0902/OLCSG0905 Study

在接受吉非替尼诱导治疗和放化疗后疾病进展的EGFR突变型III期非小细胞肺癌患者中,使用EGFR酪氨酸激酶抑制剂进行再次治疗:LOGIK0902/OLCSG0905研究的疗效和安全性分析

Saeki, Sho; Hotta, Katsuyuki; Sakata, Shinya; Oda, Naohiro; Inoue, Koji; Tamura, Tomoki; Toyozawa, Ryo; Harada, Daijiro; Tanaka, Kentaro; Inoue, Koji; Shioyama, Yoshiyuki; Gemba, Kenichi; Sasaki, Tomonari; Bessho, Akihiro; Kishimoto, Junji; Katsui, Kuniaki; Kiura, Katsuyuki; Sugio, Kenji

Correction: Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up

更正:纳武利尤单抗联合二甲双胍治疗晚期胰腺癌的持久疗效:一例随访七年的病例报告

Sato, Ryosuke; Hotta, Katsuyuki; Kubo, Toshio; Horiguchi, Shigeru; Kato, Hironari; Matsumoto, Kazuyuki; Kozuki, Toshiyuki; Udono, Heiichiro; Kiura, Katsuyuki; Otsuka, Motoyuki

Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

晚期非小细胞肺癌患者免疫化疗期间体重减轻的频率和意义

Taoka, Masataka; Ichihara, Eiki; Yokoyama, Toshihide; Inoue, Koji; Tamura, Tomoki; Sato, Akiko; Oda, Naohiro; Kano, Hirohisa; Nakamura, Kayo; Kawai, Haruyuki; Inoue, Masaaki; Ochi, Nobuaki; Fujimoto, Nobukazu; Ichikawa, Hirohisa; Ando, Chihiro; Oze, Isao; Kiura, Katsuyuki; Maeda, Yoshinobu; Hotta, Katsuyuki

Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study

EGFR突变型非小细胞肺癌患者接受免疫检查点抑制剂治疗的临床特征:CS-Lung-003前瞻性观察登记研究

Kuribayashi, Tadahiro; Ohashi, Kadoaki; Nishii, Kazuya; Ninomiya, Kiichiro; Tsubata, Yukari; Ishikawa, Nobuhisa; Kodani, Masahiro; Kanaji, Nobuhiro; Yamasaki, Masahiro; Fujitaka, Kazunori; Kuyama, Shoichi; Takigawa, Nagio; Fujimoto, Nobukazu; Kubota, Tetsuya; Inoue, Masaaki; Fujiwara, Keiichi; Harita, Shingo; Takata, Ichiro; Takada, Kenji; Okawa, Sachi; Kiura, Katsuyuki; Hotta, Katsuyuki

Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report

老年EGFR突变肺癌合并肺结核患者接受奥希替尼联合抗结核治疗:病例报告

Matsuura, Hiroaki; Higo, Hisao; Kuribayashi, Tadahiro; Tamaoki, Akihiko; Nakasuka, Takamasa; Uno, Mari; Makimoto, Go; Ninomiya, Kiichiro; Fujii, Masanori; Rai, Kammei; Ichihara, Eiki; Hotta, Katsuyuki; Miyahara, Nobuaki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki; Ohashi, Kadoaki